Join us on the latest episode! Our Guest: Greg Divis, CEO at Avadel Pharmaceuticals

What you'll get out of this episode:

• Discussing LUMRYZ, a new narcolepsy drug.
• Insights into the challenges of narcolepsy treatment.
• Avadel's future plans in healthcare innovation.

To learn more about Greg and Avadel Pharmaceuticals:
Guest LinkedIn: https://www.linkedin.com/in/greg-divis-a525334/
Website: https://www.avadel.com/
Company LinkedIn: https://www.linkedin.com/company/avadelpharmaceuticals/

Our sponsor for this episode are:
Sage Growth Partners https://sage-growth.com/

BioBreakthroughs is part of the Slice of Healthcare podcast network:
LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/